Division of Pediatric Cardiology

New legislation requiring that automated external defibrillators (AED) be located within 1,000 feet of any high school athletic activity in Tennessee is a win-win for a team of physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Monroe Carell Jr. Children’s Hospital at Vanderbilt's Jonathan Soslow, MD, and Bryan Burnette, MD, recently began treating patients with a novel gene therapy for Duchenne muscular dystrophy.

An imaging-based risk score can identify patients with Duchenne muscular dystrophy who are at greater risk of early mortality, allowing more intensive treatment and potentially prolonging life.

Steroids are commonly given to infants during open-heart surgery to reduce inflammation, but whether the drugs significantly improve patient outcomes has not been settled — until now.

When high school student Linton Beck suffered a cardiac event in class, his teachers knew just want to do thanks to automated external defibrillator training provided by Monroe Carell Jr. Children's Hospital at Vanderbilt.

The Duchenne Muscular Dystrophy Clinic at Monroe Carell Jr. Children’s Hospital at Vanderbilt has been recognized as a Certified Duchenne Care Center Program by the Parent Project Muscular Dystrophy, and is the only center in Tennessee to receive the distinction.

Vanderbilt researchers have found that children with a genetic makeup that predicts high blood pressure as adults are more likely to survive congenital heart defect repair surgery.